Literature DB >> 6604693

Identification and partial purification of human T lymphocyte colony-enhancing factor (LCEF), distinct from T cell-growth factor.

M M Werber, D Daphna, J Goldman, D Joseph, J Radnay, L A Rozenszajn.   

Abstract

Colony growth of T lymphocytes in a soft agar culture system, following stimulation with phytohaemagglutinin (PHA), is enhanced by T cell-derived conditioned medium (CM). The putative enhancing factor present in this CM has been termed lymphocyte colony-enhancing factor (LCEF). The purification of LCEF from CM has been complicated by the fact that active CM could be obtained only in the presence of 7-8 mg/ml of serum proteins. In order to circumvent this problem, CM which was shown to be active in the colony formation assay, was produced in the presence of a serum fraction precipitated by 1.6 M ammonium sulphate (AS). The first step of the purification of this CM was fractionation by 1.6 M AS, whereby the active material was fully recovered in the supernatant. The 20-fold purified material was applied on a DEAE-cellulose column. Two peaks of activity were obtained using the colony formation assay. The purification achieved by this second step was 5-10 fold for the first peak, eluting around 0.06 M NaCl, and two- to three-fold for the second peak, eluting around 0.19 M NaCl. Two peaks of activity were also obtained upon hydrophobic chromatography on a phenyl-Sepharose column, with enhancement factors of 5-8 for the first peak and 25-60 for the second peak. These results imply the presence of more than one LCEF molecule in the original CM. None of the LCEF-active fractions contained any T cell-growth factor (TCGF) activity; LCEF seems therefore to be a molecular entity distinct from TCGF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604693      PMCID: PMC1454340     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture.

Authors:  L A Rozenszajn; D Shoham; I Kalechman
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Development of colonies in vitro of mitogen-stimulated mouse T lymphocytes.

Authors:  B Sredni; Y Kalechman; H Michlin; L A Rozenszajn
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

3.  Human T cell growth factor. I. Optimal conditions for its production.

Authors:  J M Alvarez; A Silva; M O de Landazuri
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Functional and morphologic characterization of human T cells continuously grown in vitro.

Authors:  F W Ruscetti; D A Morgan; R C Gallo
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Induction of colony formation in vitro by human lymphocytes.

Authors:  E Fibach; E Gerassi; L Sachs
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

6.  Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF).

Authors:  A Zeevi; I Goldman; L A Rozenszajn
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

7.  Colony growth of human T lymphocytes in agar: effect of a soluble factor from adherent cells.

Authors:  M H Claësson; S Whittingham; M B Rodger; A W Burgess
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

8.  Regulation of human T cell colonies by an inducing activity (TCI) produced by normal human and malignant mouse cells.

Authors:  E Gerassi; L Sachs
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

9.  Differences in the formation of normal T lymphocyte colonies by peripheral blood cells from patients with chronic lymphocytic leukemia and Hodgkin's disease.

Authors:  D Douer; L Sachs
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders.

Authors:  R Foa; D Catovsky
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

View more
  4 in total

1.  Relationship between IL-2 and human T cell colony formation.

Authors:  M D Mossalayi; J C Lecron; J Tanzer; P Goube de Laforest
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

2.  Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.

Authors:  M M Werber; J Goldman; J Radnay; S Klein; L A Rozenszajn
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

3.  Control of human T-colony formation by interleukin-2.

Authors:  M Jourdan; T Commes; B Klein
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

4.  Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.

Authors:  T Suzawa; S Hyodo; T Kishi; H Kashiwa; T Karakawa; E Kittaka; T Sakano; T Usui
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.